Literature DB >> 30521862

Antiasthmatic potential of Zizyphus jujuba Mill and Jujuboside B. - Possible role in the treatment of asthma.

Prafull Bandopant Ninave1, Savita Dattatray Patil2.   

Abstract

Zizyphus jujuba Mill, a famous oriental traditional medicine, has been reported to exhibit diverse activities in biological systems including the respiratory system. However, a little information is available on its antiasthmatic activity. Jujuboside B (JB) is a natural saponin and one of the active constituent of fruits of Zizyphus jujuba. In the present investigation, JB was isolated from ethanolic extracts of fruits of Zizyphus jujuba (EZJF). EZJF and JB were then evaluated for anti-asthmatic activity using various screening methods. JB was additionally evaluated using ovalbumin (OVA) -induced allergic asthma in mice. Results obtained in the present study showed that EZJF and JB significantly inhibited clonidine-induced catalepsy, milk-induced leucocytosis and eosinophilia, clonidine-induced mast cell degranulation, and passive paw anaphylaxis. The number of inflammatory cells in bronchoalveolar lavage (BAL) fluid was considerably lowered and the severity of pulmonary inflammation was alleviated in the mice pretreated with JB. The high-level expression of T-helper type 2 (TH2) cytokines was markedly reduced in the serum, BAL fluid, and lung homogenates. Thus EZJF and JB showed potent anti-asthmatic activity. Hence EZJF and JB possess a potential role in the treatment of asthma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allergic asthma; BAL fluid; Inflammation; Jujuboside B; TH2 cytokines; Zizyphus jujuba

Mesh:

Substances:

Year:  2018        PMID: 30521862     DOI: 10.1016/j.resp.2018.12.001

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  Megasporogenesis, microsporogenesis, and female and male gametophyte development in Ziziphus jujuba Mill.

Authors:  Ye Guo; Xiang Li; Feiyi Huang; Xiaoming Pang; Yingyue Li
Journal:  Protoplasma       Date:  2019-06-10       Impact factor: 3.356

2.  Polystichum braunii ameliorates airway inflammation by attenuation of inflammatory and oxidative stress biomarkers, and pulmonary edema by elevation of aquaporins in ovalbumin-induced allergic asthmatic mice.

Authors:  Ammara Saleem; Afza Mubeen; Muhammad Furqan Akhtar; Alam Zeb
Journal:  Inflammopharmacology       Date:  2022-03-07       Impact factor: 4.473

3.  Hepatoprotective functions of jujuboside B.

Authors:  Chaeyeong Kim; Yun Hee Jeong; Nayeon Kim; Soo Ho Ryu; Jong-Sup Bae
Journal:  J Nat Med       Date:  2022-09-06       Impact factor: 3.192

Review 4.  A Review of Edible Jujube, the Ziziphus jujuba Fruit: A Heath Food Supplement for Anemia Prevalence.

Authors:  Jianping Chen; Karl W K Tsim
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

Review 5.  Research advances in bioactive components and health benefits of jujube (Ziziphus jujuba Mill.) fruit.

Authors:  Yang Lu; Tao Bao; Jianling Mo; Jingdan Ni; Wei Chen
Journal:  J Zhejiang Univ Sci B       Date:  2021-06-15       Impact factor: 3.066

6.  Inhibitory Effects of Gyeji-Tang on MMP-9 Activity and the Expression of Adhesion Molecules in IL-4- and TNF-α-Stimulated BEAS-2B Cells.

Authors:  Yu Jin Kim; Woo-Young Jeon; Youn-Hwan Hwang; Mee-Young Lee
Journal:  Plants (Basel)       Date:  2021-05-10

7.  Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling.

Authors:  Zaixiong Ji; Jiaqi Li; Jianbo Wang
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

8.  Banhahubak-Tang Tablet, a Standardized Medicine Attenuates Allergic Asthma via Inhibition of Janus Kinase 1 (JAK1)/ Signal Transducer and Activator of Transcription 6 (STAT6) Signal Pathway.

Authors:  Yeon Kyung Nam; Seong Chul Jin; Mi Hye Kim; La Yoon Choi; Yong-Bok Lee; Woong Mo Yang
Journal:  Molecules       Date:  2020-05-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.